Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05785026 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Menthol for Dyspnea Relief in Health and COPD

Study acronym: MENTHODYSC
StatusRecruiting
PhaseNot applicable
SponsorKU Leuven
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion date: Dec 31, 2026 to Oct 31, 2028v3 Show 4 more changesShow less
    • Study completion date: Jun 30, 2027 to Oct 31, 2028
    • Interventions: Menthol inhalation (Other), Strawberry scent (Other) to Menthol inhalation (Other), Menthol inhalation and airflow to leg (Other), Menthol inhalation and facial airflow (Other), Strawberry…
    • Study arms: 9 to 13
    • Study description expanded, about 2 words
  2. Minor Re-verified, no change to tracked fieldsv2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
69 trials monitored
See all monitored trials
1,119 trials monitored
See 34 trials at risk
Menthol inhalation (MI) is a novel and promising treatment option for acute relief of dyspnea, however, the underlying ventilatory and/or neural related mechanisms for this relief in symptoms remain unknown. The overall aim of this research project is to systematically examine the mechanisms of dyspnea relief from MI in healthy individuals and those with COPD.
Trial Details
NCT Number NCT05785026
Lead Sponsor KU Leuven
Conditions
(from sponsor)
Dyspnea, Chronic Obstructive Pulmonary Disease
Related terms Dyspnea, Pulmonary Disease, Chronic Obstructive
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov